Teva's recall of U.S.-made drugs latest example of contamination fears in generic marketplace; report says Lilly, Pfizer and former Mylan plant in Morgantown have been cited in the past | WV News | wvnews.com
Metformin - Wikipedia
Granules Pharma Recalls Diabetes Drug Metformin HCI Extended-Release Tablets
Excessive levels of NDMA prompt Recalls of Metformin
Impurities Found in Diabetes Rx | RxWiki
Diabetes Drug, Metformin, Recalled for Cancer-Causing Contamination
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA
Popular diabetes medication recalled by two more pharmaceutical companies - pennlive.com
Stopping metformin: Side effects, risks, and how to stop safely
FDA Issues Metformin Recall
Diabetes drug metformin is being investigated over contamination fears | Daily Mail Online
Type 2 Diabetes Drug Manufacturer Recalls 76 More Lots For Cancer Concerns
Teva Recalls U.S.-Made Drugs Following Contamination Fears
Additional Metformin Products Recalled | RxWiki
Meformin Recall for Diabetes Drug | Everyday Health
Companies Recall Extended-Release Metformin due to Cancer-Causing Substance | diaTribe
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA) | FDA
Recall of medicines diabetes due to carcinogenic substance - World Today News
Metformin Recalls Ballooned in 2020 | MedPage Today
Recall alert: Manufacturers expand diabetes drug recall over excess cancer-causing compound levels – KIRO 7 News Seattle
Grow Midwives - *Important to Metformin users and prescribers. 14 Lots of 500 and 750 mg Extended Release dose being immediately recalled. Announcement released by the FDA this evening. https://bit.ly/30cUqB7. “Teva is
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg